Approximately half of people with early-stage NSCLC still experience a cancer recurrence following surgery. This video explains how doctors try to reduce the risk of lung cancer returning
Dr. Tom Grogan has spent a lifetime discovering smarter, safer, better ways to diagnose cancer. That’s why his own diagnosis of malignant melanoma came as a shock.
Roche’s scientists are leading pioneers in immune biology and cancer research, which is resulting in innovative and personalised treatment options in cancer.
Roche are leading in cancer immunotherapy through innovative research, including immune profiling, with the goal to develop treatment tailored to individuals.
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)